Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value ($000): $1,390,516 (91.1% shares, 8.9% debt)

Holdings (19)

VTI VANGUARD INDEX FDS 22.9%

Value ($000) $318,823 Shares 2,979,100 Est. Cost $57.39 Unrealized —

— OPHTHOTECH CORP 18.4%

Value ($000) $255,640 Shares 4,910,487 Est. Cost $32.35 Unrealized —

INGN INOGEN INC 11.4%

Value ($000) $158,300 Shares 3,549,320 Est. Cost $17.78 Unrealized +115.8%

— WRIGHT MEDICAL GROUP 8.9%

Value ($000) $123,949 Shares 4,720,065 Est. Cost $2.50 Unrealized —

VGK VANGUARD INTL EQUITY INDEX F 8.2%

Value ($000) $113,412 Shares 2,101,000 Est. Cost $45.01 Unrealized —

— ALDER BIOPHARMACEUTICALS INC 7.4%

Value ($000) $103,354 Shares 1,951,183 Est. Cost $20.07 Unrealized —

— NEVRO CORP 5.9%

Value ($000) $82,007 Shares 1,525,704 Est. Cost $38.67 Unrealized —

— FLEXION THERAPEUTICS INC 3.4%

Value ($000) $46,694 Shares 2,133,131 Est. Cost $17.27 Unrealized —

— TOBIRA THERAPEUTICS INC 3.3%

Value ($000) $46,513 Shares 2,696,405 Est. Cost $17.25 Unrealized —

ADAPY ADAPTIMMUNE THERAPEUTICS PLC 2.3%

Value ($000) $32,290 Shares 1,761,567 Est. Cost $18.33 Unrealized —

— COLUCID PHARMACEUTICALS INC 2.0%

Value ($000) $27,203 Shares 3,056,563 Est. Cost $8.90 Unrealized —

— OTONOMY INC 1.4%

Value ($000) $20,117 Shares 875,025 Est. Cost $24.00 Unrealized —

— TOKAI PHARMACEUTICALS INC 1.2%

Value ($000) $16,469 Shares 1,238,252 Est. Cost $14.41 Unrealized —

AKBA AKEBIA THERAPEUTICS INC 1.1%

Value ($000) $15,604 Shares 1,516,387 Est. Cost $24.08 Unrealized -64.6%

— HTG MOLECULAR DIAGNOSTICS INC 1.0%

Value ($000) $14,274 Shares 1,280,185 Est. Cost $11.15 Unrealized —

— INVUITY INC 0.8%

Value ($000) $10,457 Shares 740,616 Est. Cost $14.12 Unrealized —

GKOS GLAUKOS CORP 0.2%

Value ($000) $2,174 Shares 75,000 Est. Cost $29.05 Unrealized 0.0%

— AERIE PHARMACEUTICALS INC 0.1%

Value ($000) $1,765 Shares 100,000 Est. Cost $29.19 Unrealized —

XENE XENON PHARMACEUTICALS INC 0.1%

Value ($000) $1,471 Shares 127,563 Est. Cost $14.68 Unrealized -5.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	2,979,100	$318,823	22.9%	$57.39	—	TOTAL STK MKT	922908769
—	OPHTHOTECH CORP	4,910,487	$255,640	18.4%	$32.35	—	COM	683745103
INGN	INOGEN INC	3,549,320	$158,300	11.4%	$17.78	+115.8%	COM	45780L104
—	WRIGHT MEDICAL GROUP	4,720,065	$123,949	8.9%	$2.50	—	CONTINGENT VALUE RIGHTS	98235T115
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$113,412	8.2%	$45.01	—	FTSE EUROPE ETF	922042874
—	ALDER BIOPHARMACEUTICALS INC	1,951,183	$103,354	7.4%	$20.07	—	COM	014339105
—	NEVRO CORP	1,525,704	$82,007	5.9%	$38.67	—	COM	64157F103
—	FLEXION THERAPEUTICS INC	2,133,131	$46,694	3.4%	$17.27	—	COM	33938J106
—	TOBIRA THERAPEUTICS INC	2,696,405	$46,513	3.3%	$17.25	—	COM	88883P101
ADAPY	ADAPTIMMUNE THERAPEUTICS PLC	1,761,567	$32,290	2.3%	$18.33	—	SPONDS ADR	00653A107
—	COLUCID PHARMACEUTICALS INC	3,056,563	$27,203	2.0%	$8.90	—	COM	19716T101
—	OTONOMY INC	875,025	$20,117	1.4%	$24.00	—	COM	68906L105
—	TOKAI PHARMACEUTICALS INC	1,238,252	$16,469	1.2%	$14.41	—	COM	88907J107
AKBA	AKEBIA THERAPEUTICS INC	1,516,387	$15,604	1.1%	$24.08	-64.6%	COM	00972D105
—	HTG MOLECULAR DIAGNOSTICS INC	1,280,185	$14,274	1.0%	$11.15	—	COM	40434H104
—	INVUITY INC	740,616	$10,457	0.8%	$14.12	—	COM	46187J106
GKOS	GLAUKOS CORP	75,000	$2,174	0.2%	$29.05	0.0%	COM	377322102
—	AERIE PHARMACEUTICALS INC	100,000	$1,765	0.1%	$29.19	—	COM	00771V108
XENE	XENON PHARMACEUTICALS INC	127,563	$1,471	0.1%	$14.68	-5.8%	COM	98420N105